Ju-yeon Jeong

发表

Management Outcome and Clinical Manifestation of Posterior Circulation Aneurysms VS. Anterior Circulation Aneurysm.

Kim Ts, Ju-yeon Jeong, Kim Gk, 2001 .

Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein–Barr Virus-Infected Gastric Cancer Cells

K. Hahm, S. Hong, J. Cho, 2019, Molecules and cells.

miR-22-3p and miR-30e-5p Are Associated with Prognosis in Cervical Squamous Cell Carcinoma

H. An, Haeyoun Kang, Gwangil Kim, 2022, International journal of molecular sciences.

Effect of Adipose-Derived Mesenchymal Stem Cell Administration and Mild Hypothermia Induction on Delayed Neuronal Death After Transient Global Cerebral Ischemia

S. Suh, Bo Young Choi, S. Chung, 2017, Critical care medicine.

Predictors of the Response to Gefitinib in Refractory Non–Small Cell Lung Cancer

Y. Kim, Youngchul Kim, Chang‐Soo Park, 2005, Clinical Cancer Research.

Comparison of PCR-RFLP and Real-Time PCR for Allelotyping of Single Nucleotide Polymorphisms of RRM1, a Lung Cancer Suppressor Gene

Youngchul Kim, I. Oh, K. S. Kim, 2007 .

Microsatellite Alterations of Plasma DNA in Non-Small Cell Lung Cancer

Youngchul Kim, I. Oh, Kyu-Sik Kim, 2005 .

Plasma heart-type fatty acid binding protein level in acute ischemic stroke: Comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome

O. Kim, Seung-Hun Oh, H. Ahn, 2013, Clinical Neurology and Neurosurgery.

A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer.

H. An, J. Y. Park, Kyung-Soon Park, 2019, Gynecologic oncology.

VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients.

H. An, Haeyoun Kang, J. Heo, 2015, Stem cells and development.

Notch3‐specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel‐resistant ovarian cancer cells

H. An, Haeyoun Kang, Tae Hoen Kim, 2016, Molecular carcinogenesis.

Overexpression of goosecoid homeobox is associated with chemoresistance and poor prognosis in ovarian carcinoma.

H. An, Ju-yeon Jeong, Yoolee Kim, 2014, Oncology reports.

MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance

H. An, Kwang-il Kim, Kwang-il Kim, 2013, Journal of Ovarian Research.

Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy

H. An, Haeyoun Kang, K. Cho, 2022, Cell & Bioscience.

Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer

S. Lim, Joo‐Hang Kim, H. An, 2020, Scientific Reports.

Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas

H. An, Sewha Kim, M. Choi, 2019, Journal of Cancer.

Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p.

H. An, M. Choi, S. Jung, 2014, Gynecologic oncology.

miR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3

H. An, Haeyoun Kang, Tae Hoen Kim, 2017, Oncotarget.

Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer.

H. An, H. Jeong, Gwangil Kim, 2016, Lung cancer.

Clinical Impact of microRNAs Associated With Cancer Stem Cells as a Prognostic Factor in Ovarian Carcinoma

H. An, Sohyun Hwang, Ju-yeon Jeong, 2017, Journal of Cancer.

miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.

H. An, Haeyoun Kang, Tae Hoen Kim, 2015, Cancer letters.

Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers

H. An, Ju-yeon Jeong, Tae-Heon Kim, 2013, Apoptosis.

A Clinical Analysis of Chronic Subdural Hematoma according to Age Factor.

Kim Ts, Ju-yeon Jeong, Kim Gk, 2000 .

Phase III Clinical Trial of Revaprazan (Revanex(R)) for Gastritis

K. Hahm, J. Rew, Myung-Gyu Choi, 2006 .

Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy

Jong-Seok Moon, J. Ahn, Kyunggi Cho, 2023, Inflammation Research.

Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids

H. An, M. Choi, S. Jung, 2020, Journal of Ovarian Research.

Correlation of ALDH1 and Notch3 Expression: Clinical implication in Ovarian Carcinomas

Ah-Ram Kim, Y. Ko, H. An, 2017, Journal of Cancer.

Combining Erlotinib with Cytotoxic Chemotherapy May Overcome Resistance Caused by T790M Mutation of EGFR Gene in Non-Small Cell Lung Carcinoma

I. Oh, Hyun-Ju Cho, K. S. Kim, 2009 .

Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion

D. Park, Tae Hoen Kim, Gee Hoon Lee, 2021, Yonsei medical journal.

Peroxiredoxin‐I is an autoimmunogenic tumor antigen in non‐small cell lung cancer

H. Chae, Z. Park, Y. Yoo, 2005, FEBS letters.

MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.

H. An, Haeyoun Kang, Tae Hoen Kim, 2017, Cancer letters.

Efficacy of Gemcitabine in Patients with Non–Small Cell Lung Cancer According to Promoter Polymorphisms of the Ribonucleotide Reductase M1 Gene

I. Oh, Kyu-Sik Kim, Yong-Soo Kwon, 2008, Clinical Cancer Research.

Phase III Clinical Trial of Revaprazan (Revanex) for Gastritis

K. Hahm, J. Rew, Myung-Gyu Choi, 2006 .

Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer

S. Lim, Joo‐Hang Kim, H. An, 2020, Scientific Reports.

USP19 and RPL23 as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma

H. An, Haeyoun Kang, Gwangil Kim, 2021, Cancers.

Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers

H. An, Ju-yeon Jeong, Tae-Heon Kim, 2013, Apoptosis.

Comparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness Marker

Jong-Seok Moon, J. Ahn, Kyunggi Cho, 2023, Brain tumor research and treatment.

Overexpression of goosecoid homeobox is associated with chemoresistance and poor prognosis in ovarian carcinoma.

H. An, Ju-yeon Jeong, Yoolee Kim, 2014, Oncology reports.